This is an H1: Our committment to being the leader in responsible pain management

Collegium Pharmaceutical is a specialty pharmaceutical company committed to being the leader in responsible pain management. For nearly two decades, Collegium has been focused on developing and commercializing new medicines for pain management that reflect our Core Values and our commitment to people suffering from pain, providers and our communities. The result of those efforts is a portfolio of meaningfully differentiated medications to treat moderate to severe pain.

This is an H2: Acute and chronic pain impact millions of Americans every year

There are two broad categories of pain: acute pain, or pain that is self-limited and generally requires treatment for no more than up to a few weeks, and chronic pain, or pain that lasts beyond the healing of an injury or that persists longer than three to six months. Between 50-100 million adults in the U.S. are affected by chronic pain each year, and as many as 19.6 million of those adults experience high-impact chronic pain that interferes with daily life or work activities. Prescription opioids continue to serve as important tools in the treatment of acute and chronic pain where alternative treatments have proven inadequate.

  • Lorem ipsum dolor sit amet, consectetur adipiscing elit.
  • Sed quis massa eu purus venenatis imperdiet at vitae ipsum.
  • Maecenas fermentum risus et odio cursus mattis.
  • Aenean nec est sed diam iaculis interdum ac sed risus.
  • Vivamus ac leo mattis, blandit nibh ac, sagittis erat.
  • Nam suscipit nisl at arcu vulputate, vel aliquet nibh finibus.

This is an H3: Opioid abuse is an epidemic in the United States

The misuse, abuse and diversion of prescription opioids have contributed to today’s opioid crisis, which in 2017, was estimated by the Centers for Disease Control and Prevention to have claimed the lives of more than 17,000 people in the U.S.

This is an H4

# First Name Last Name Username
1 Mark Otto @mdo
2 Jacob Thornton @fat
3 Larry the Bird @twitter